Media Pack
News

Current Edition

Volume 16 Issue 3
 
 
Gaining Traction on Rare Disease Treatments
Volume 11 Issue 2

Gaining Traction on Rare Disease Treatments

While their prevalence in the United States (US) may be relatively low, ‘rare’ diseases have been garnering increasing attention in recent years through such channel...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Reimagining the Pharmaceutical Life Cycle with Artificial Intelligence
Volume 11 Issue 2

Reimagining the Pharmaceutical Life Cycle with Artificial Intelligence

From discovery to clinical trials, to marketing and managing medicinal products on the market, artificial intelligence (AI) is delivering promise and possibility to ...
25 April 2019 Volume 11 Issue 2
Continue Reading →
After a Slow Start, US Biosimilar Approvals Accelerated in 2018
Volume 11 Issue 2

After a Slow Start, US Biosimilar Approvals Accelerated in 2018

The US Food and Drug Administration (FDA) has approved eight biosimilars since May 2018 – seven in 2018 and one more in January 2019 – nearly doubling the number app...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Clinical Research in Latin America – The New Frontier
Volume 11 Issue 2

Clinical Research in Latin America – The New Frontier

With the rapid transformation and the global growth of clinical trials, controlling the cost and achieving more effective investment of the resources that small star...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Insurance in Clinical Trials
Volume 11 Issue 2

Insurance in Clinical Trials

Clinical trial insurance is intended to compensate patientvolunteers (“volunteers”) in a clinical trial (or their dependents) for death or injury arising out of thei...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Want to Get the Most Out of Patient-centric Trials? Make Sure They’re Site-centric, Too
Volume 11 Issue 2

Want to Get the Most Out of Patient-centric Trials? Make Sure They’re Site-centric, Too

The push by pharma companies to develop more targeted compounds in response to unmet medical needs, and the large return on investment these successful therapies gen...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Biologic Medicines and Patient-centricity – A New Phase of Hope
Volume 11 Issue 2

Biologic Medicines and Patient-centricity – A New Phase of Hope

The global pharmaceutical industry has entered an exciting new era of drug development, bringing new hope to patients around the world. It is estimated that close to...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Challenges in Recruiting Early-phase Trial Populations
Volume 11 Issue 2

Challenges in Recruiting Early-phase Trial Populations

Any issues in the recruitment and retention of subjects for a clinical trial can result in delays and unnecessary costs, and may even potentially undermine its resul...
25 April 2019 Volume 11 Issue 2
Continue Reading →
Survey Highlights Patient Recruitment Challenges in Duchenne Muscular Dystrophy Clinical Trials
Volume 11 Issue 2

Survey Highlights Patient Recruitment Challenges in Duchenne Muscular Dystrophy Clinical Trials

Although Duchenne Muscular Dystrophy (DMD) is a rare disease, multiple targets are being pursued to find treatments. As a result, DMD patients have several options w...
25 April 2019 Volume 11 Issue 2
Continue Reading →
The Future of Cardiovascular Outcomes Trials in Diabetes
Volume 11 Issue 2

The Future of Cardiovascular Outcomes Trials in Diabetes

Patients with diabetes have an up to 50% increased risk of cardiovascular (CV) disease (CVD) compared to individuals without diabetes. Optimisation of glycaemic cont...
25 April 2019 Volume 11 Issue 2
Continue Reading →
 
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte